CORDRAN LOTION Rx
Generic Name and Formulations:
Indications for CORDRAN LOTION:
Adults and Children:
Shake well before use. Rub small amount into affected areas 2–3 times daily; discontinue when control is achieved. Do not occlude.
Tape: Serum-exuding lesions. Intertrigo.
Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis or on pre-existing skin atrophy. Avoid tight-fitting diapers or plastic pants. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Treat infection if present; discontinue if infection persists or worsens. Use lowest effective dose and potency (esp. in children). Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infections, skin atrophy, striae, miliaria; HPA axis suppression (esp. in children).
Crm 0.025%, 0.05%—120g; Oint 0.05%—60g, 120g; Lotion—15mL, 60mL, 120mL; Tape (roll) 3in x 24in, 3in x 80in—1
Endocrinology Advisor Articles
- Behavioral Weight Loss Interventions May Prevent Obesity
- PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes
- Association Between Urine Complement Proteins and Kidney Disease, Mortality in T2D
- Rates of Incident Type 2 Diabetes in Chronic Kidney Disease
- Availability and Affordability of Diabetes Medication Worldwide
- Estradiol, Cortisol, TGF-β1 Involved in Thyroid Immunity During Pregnancy and Postpartum
- Pharmacotherapy Personalization May Optimize Outcomes for Type 2 Diabetes
- Late-Onset Epilepsy Linked to Diabetes
- Examining the Ethical Considerations of Grateful Patient Fundraising
- Muscle Cell Proﬁles Relate to Exercise Response Variation in Type 2 Diabetes